Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- Check6 days agoChange DetectedAdded a new press release item for November 5, 2025 about ARCHER trial results to be presented at the ESC, and updated the stock quote panel; the older MAVERIC enrollment press release was removed.SummaryDifference1%

- Check13 days agoChange DetectedStock ticker values in the header were updated from $1.19 NASDAQ:CRDL and $1.66 TSX:CRDL to $1.13 NASDAQ:CRDL and $1.54 TSX:CRDL.SummaryDifference1%

- Check20 days agoChange DetectedThe TSX:CRDL price displayed in the investor widget updated from 1.67 to 1.66.SummaryDifference0.2%

- Check27 days agoChange DetectedMajor update: replaces a March 2025 conference notice with a October 2025 financing press release, shifting the page focus from a past events note to a current funding update.SummaryDifference13%

- Check34 days agoChange DetectedPrices on the page have been updated: new listed amounts include $1.04 and $1.46, replacing previous amounts of $1.07 and $1.49.SummaryDifference1%

- Check41 days agoChange DetectedPrices were updated: removed $1.08 and $1.51 and added $1.07 and $1.49.SummaryDifference1%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.